Special items: Ovarian Cancer and Us blog best viewed in Firefox

Tuesday, January 19, 2010

Pharma Pipeline News: Preliminary results from Nektar Therapeutics' NKTR-102 Phase 2 study in platinum-resistant ovarian cancer

Note: conference reporting news item

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.